Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit
IL-4 and IL-13 are key and central drivers of type 2 inflammation1-3

IL-4 and IL-13 are key and central drivers of type 2 inflammation1-3

Module 1: An update on RACGP guidelines - Refreshing Key Concepts of Type 2 Diabetes

Module 1: An update on RACGP guidelines - Refreshing Key Concepts of Type 2 Diabetes

The updated RACGP guidelines on the management of type 2 diabetes is an important primary care tool that provides GPs and other health professionals with information and recommendations based on the latest body of evidence.

Prof. Rory McCrimmon: Patients at Risk of Hypoglycaemia

Prof. Rory McCrimmon: Patients at Risk of Hypoglycaemia

Hypoglycaemia is a common and serious complication of diabetes, particularly affecting your patients on insulin therapy. It can have serious acute and long-term impacts.1,2

Type 2 inflammation in CRSwNP

Type 2 inflammation in CRSwNP

About Fabry Disease

About Fabry Disease

Sophie, Australia. Fabry Disease. (Image used with permission.)

The More Biomarkers the Better When Deciding on Treatment for Severe Uncontrolled Asthma?

The More Biomarkers the Better When Deciding on Treatment for Severe Uncontrolled Asthma?

Watch Professor Peter Wark’s podcast as he discusses the importance of biomarkers and how they can be used to inform treatment decisions for your patients

Treatment options for Atopic dermatitis

Treatment options for Atopic dermatitis

Type 2 Inflammation drives Atopic dermatitis

Type 2 Inflammation drives Atopic dermatitis

The stigma of diabetes, Prof. Jane Speight

The stigma of diabetes, Prof. Jane Speight

Negative community attitudes and stereotypes can affect people who live with diabetes, impacting self-care, physical health, mental health and quality of life.1 In this webinar, Prof. Jane Speight discusses the research on diabetes stigma, describing the experiences of stigma, its consequences, the importance of language and how healthcare professionals can be a part of the solution.

Understanding Atopic dermatitis

Understanding Atopic dermatitis

SINUS-24 and SINUS-52 publication

SINUS-24 and SINUS-52 publication

Clinical Trial Program in CRSwNP

Clinical Trial Program in CRSwNP